A Agilent Technologies

Q3 2025 10-Q

Filed: Aug 29, 2025Period ending Jul 31, 2025

Health Care

Laboratory Analytical InstrumentsSEC EDGAR

Agilent Technologies (A) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Aug 29, 2025 for the fiscal period ending Jul 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

• New risk: Continuing US federal agencies funding under resolution expiring Sept 30, 2025 may impact sales to federally funded customers
• Material update: Increased risks from geopolitical conflicts (Ukraine/Russia, Middle East) and trade uncertainties affecting international operations

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.7B

Net Income

$336M

Operating Margin

20.7%

Net Margin

19.3%

Source: XBRL data from Agilent Technologies Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Agilent Technologies Quarterly Reports

Q1 2026 10-Q

Get deeper insights on Agilent Technologies

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.